Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State University.
Levine MD, Wagner VM, Riedinger CJ, Khadraoui W, Haight PJ, Morton M, Barrington DA, Calo CA, Castaneda AV, Lightfoot M, Chalif J, Gonzalez A, Cohn DE. Levine MD, et al. Among authors: barrington da. Gynecol Oncol Rep. 2024 Jan 29;52:101327. doi: 10.1016/j.gore.2024.101327. eCollection 2024 Apr. Gynecol Oncol Rep. 2024. PMID: 38390623 Free PMC article. Review.
Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.
Levine MD, Pearlman R, Hampel H, Cosgrove C, Cohn D, Chassen A, Suarez A, Barrington DA, McElroy JP, Waggoner S, Nakayama J, Billingsley C, Resnick K, Andrews S, Singh S, Jenison E, Clements A, Neff R, Goodfellow PJ; Ohio Prevention and Treatment of Endometrial Cancer Initiative Study Group. Levine MD, et al. Among authors: barrington da. JCO Precis Oncol. 2021 Nov;5:1588-1602. doi: 10.1200/PO.21.00249. JCO Precis Oncol. 2021. PMID: 34994648 Free PMC article.
High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors.
Calo CA, Barrington DA, Brown M, Gonzalez L, Baek J, Huffman A, Benedict J, Backes F, Chambers L, Cohn D, Copeland L, Cosgrove C, Nagel C, O'Malley D, Bixel K. Calo CA, et al. Among authors: barrington da. Gynecol Oncol Rep. 2022 Jul 8;42:101040. doi: 10.1016/j.gore.2022.101040. eCollection 2022 Aug. Gynecol Oncol Rep. 2022. PMID: 35855965 Free PMC article.
26 results